Breaks Categories: Stock Spotlights

ThursdayMar 29, 2018 3:43 pm

CannabisNewsBreaks – Liberty Leaf Holdings Ltd. (CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P) Strives to Attain GMP-compliant Procedures

Liberty Leaf Holdings Ltd. (CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P) continues to diversify its portfolio as the Canadian government prepares to legalize cannabis-infused edibles and beverages by mid-2019. An article discussing the company reads: “Liberty Leaf Holdings Ltd. (CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P), a vertically-integrated cannabis company with strategic investments in proven, revenue-generating businesses, is building a diversified portfolio that includes marketing a wide range of high quality, medicinal grade cannabis products with tremendous promise for both human and veterinary use. Liberty Leaf and its wholly owned subsidiary, North Road Ventures, recently signed an agreement with Cannabis Compliance Inc.…

Continue Reading

ThursdayMar 29, 2018 3:38 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Anticipates Additional Technology Licensing Contracts in 2018

Lexaria Bioscience’s (CSE: LXX) (OTCQB: LXRP) CEO Chris Bunka recently discussed the company’s plans regarding technology licensing contracts in an audio interview. An article further discussing the company reads: “LXRP is a British Columbia, Canada-based bioscience company that is a drug delivery platform innovator. The company has developed its patented DehydraTECH™ delivery technology platform, which it out-licenses to promote healthier ingestion methods and lower overall dosing. …Bunka said that LXRP believes that 6-12 more licensing contracts will be signed this year, both generating more revenue for the company and building greater shareholder value. “We’ve only just graduated from the demonstration…

Continue Reading

MondayMar 26, 2018 3:35 pm

CannabisNewsBreaks – Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) Prepares to Pounce on Canada’s Recreational Cannabis Market Following Upcoming Legalization

British Columbia-based cannabis cultivation firm Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) is currently planning its expansion strategy as the end of cannabis prohibition in Canada approaches. An article discussing the company reads: “According to the company’s investor presentation made in November, by 2021, the recreational marijuana industry that Choom™ Holdings exclusively aims to serve is expected to be almost eight times the size of the medical marijuana industry, which is served by Choom’s Medi-Can Health Solutions Ltd. subsidiary, with benefits spilling over into the tourism industry, governmental tax and licensing coffers, and paraphernalia manufacturing market. Its nimble business model…

Continue Reading

FridayMar 23, 2018 12:16 pm

CannabisNewsBreaks – Global Hemp Group, Inc. (CSE: GHG) (FRA: GHG) (OTC: GBHPF) Capitalizing on the Vast Market Potential of Hemp, CBD Products

Hemp cultivation company Global Hemp Group (CSE: GHG) (FRANKFURT: GHG) (OTC: GBHPF) remains primarily focused on the cultivation of hemp and cannabinoid extraction for both domestic and international markets. An article discussing the company reads: “Founded in 2014, Global Hemp Group is building a strategic portfolio of hemp-based companies to provide its global customer base with a consistent supply of high-quality hemp-derived products. It intends to leverage the huge market potential of hemp products to deliver significant ROI to its shareholders. The number of products that can be manufactured from the hemp plant is vast. It can be used to…

Continue Reading

FridayMar 23, 2018 11:22 am

CannabisNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Technology Mimics the Body’s Natural Creation of Pain Fighting Peptides

Health sciences company PreveCeutical Medical (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) is engaged in the development of pain relievers that mimic body’s natural pain relief peptides. An article discussing the company reads: “The linker technology that underlies PreveCeutical’s drug development platform was developed at the University of Queensland in Australia. At that impressive institution, Dr. Parekh headed a team that developed synthetic molecules capable of mimicking the endomorphins produced by the body for pain relief, as explained by PreveCeutical chairman and CEO Stephen Van Deventer in a recent video interview (http://cnw.fm/fEO5a). Although they are as potent as morphine, the effect…

Continue Reading

ThursdayMar 22, 2018 12:34 pm

CannabisNewsBreaks – Liberty Leaf Holdings Ltd. (CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P) Leverages Opportunity in Cannabis Industry through Strategic, Diversified Investments

Liberty Leaf Holdings (CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P) offers investors a unique option for diversified exposure across the entire legal cannabis market. An article discussing the company reads: “Liberty Leaf takes calculated and strategic investment positions in established, proven performers in both the medicinal and recreational legal cannabis markets. Liberty Leaf targets and then acquires and/or partners with established, revenue-producing marijuana businesses that have large upside potential. Liberty’s objective is to build a substantial, broad-based portfolio of multiple cannabis-sector businesses, including companies across the full spectrum of activities, from the cultivation and processing of legal medicinal and recreational cannabis…

Continue Reading

FridayMar 16, 2018 12:36 pm

CannabisNewsBreaks – Global Hemp Group, Inc. (CSE: GHG) (FRA: GHG) (OTC: GBHPF) Plans to Progress in Industrial Hemp Sector through Strategic Partnerships, Acquisitions

Hemp cultivation company Global Hemp Group (CSE: GHG) (FRANKFURT: GHG) (OTC: GBHPF) is on a mission to capture cash flow, generate revenues and create value for its shareholders through the execution of joint ventures, partnerships, and acquisitions. An article discussing the company reads: “Global Hemp Group, Inc. (CSE: GHG) (FRANKFURT: GHG) (OTC: GBHPF) is focused on the vital role that industrial hemp will play in building a sustainable future. The company concentrates on the production and processing of hemp to produce raw and finished goods for domestic and international markets. … Through a series of partnerships, joint ventures and acquisitions,…

Continue Reading

WednesdayMar 14, 2018 11:44 am

CannabisNewsBreaks – Liberty Leaf Holdings Ltd. (CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P) and Blox Labs, Inc. (CSE: BLOX) (OTC: BLLXF) Complete Preliminary Input and Analysis in Phase One Development of cannaBLOX

Liberty Leaf Holdings Ltd. (CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P) is working in partnership with Blox Labs, Inc. (CSE: BLOX) (OTC: BLLXF) to create cannaBLOX, a blockchain-based software smart contract platform for the legalized cannabis industry. An article discussing the joint development reads: “Liberty Leaf Holdings Ltd. (CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P) and Blox Labs, Inc. (CSE: BLOX) (OTC: BLLXF) have announced progress on their joint development of phase one of cannaBLOX, the blockchain-based smart contract platform for the legalized cannabis industry (http://cnw.fm/4DmPU). … Blox Labs is working to complete its white paper on cannaBLOX, and a satellite development…

Continue Reading

FridayMar 09, 2018 3:11 pm

CannabisNewsBreaks – Liberty Leaf Holdings Ltd. (CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P) Grows in Cannabis Industry through Strategic Investments

Liberty Leaf Holdings Ltd. (CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P) is a vertically-integrated cannabis company with strategic investments focusing on proven, revenue-generating businesses. An article discussing the company reads: “Liberty Leaf Holdings Ltd. (CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P) is a publicly traded Canadian-based company with strategic investments in businesses that are established, revenue- producing players in the medicinal and recreational cannabis market. Liberty Leaf’s focus is to build and support a diversified portfolio of cannabis-sector businesses, including those involved in the cultivation and processing of legal medicinal and recreational cannabis, value-added CBD/THC pet products, and supply-chain products for this…

Continue Reading

FridayMar 09, 2018 3:05 pm

CannabisNewsBreaks – PreveCeutical Medical Inc.’s (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Proprietary Sol-gel Formulations May Significantly Improve Bioavailability

Health sciences company PreveCeutical Medical (PRVCF) is engineering a unique Sol-gel CBD-based technology delivery platform to provide direct, controlled pharmacological drug release. This technology could provide a clinical benefit for patients seeking relief for multiple medical indications including pain, inflammation, seizures and neurological disorders. An article discussing the company’s proprietary technology reads: “PreveCeutical’s proprietary Sol-gel formulations begin as a liquid that is administrated into the nose, which then forms a gel as it is warmed in the nasal cavity where it can then be absorbed. This effectively bypasses the stomach and intestines – eliminating first pass metabolism – and may…

Continue Reading